LeMaitre Vascular, Inc. (LMAT) has a consensus analyst rating of Buy, based on 20 analysts covering the stock. Of those, 14 recommend buying, 6 recommend holding, and 0 recommend selling.
The analyst consensus price target for LMAT is $101.50, representing a -13.5% downside from the current price of $117.39. Price targets range from a low of $95.00 to a high of $108.00.
